메뉴 건너뛰기




Volumn 3, Issue 3, 2010, Pages 412-419

Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure

Author keywords

Arginine vasopressin; Experimental model; Heart failure; Kidney; Natriuretic peptides; Pharmacology; V2 receptor antagonist

Indexed keywords

ALDOSTERONE; BRAIN NATRIURETIC PEPTIDE; TOLVAPTAN; VASOPRESSIN V2 RECEPTOR; BENZAZEPINE DERIVATIVE; NATRIURETIC FACTOR; VASOPRESSIN RECEPTOR;

EID: 77954751929     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.109.916114     Document Type: Article
Times cited : (27)

References (33)
  • 4
    • 0037181511 scopus 로고    scopus 로고
    • Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial
    • Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. J Am Med Assoc. 2002;287:1531-1540.
    • (2002) J Am Med Assoc , vol.287 , pp. 1531-1540
  • 5
    • 17144392493 scopus 로고    scopus 로고
    • Short-term risk of death after treatment with nesiritide for decompensated heart failure: A pooled analysis of randomized controlled trials
    • Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. J Am Med Assoc. 2005; 293:1900-1905.
    • (2005) J Am Med Assoc , vol.293 , pp. 1900-1905
    • Sackner-Bernstein, J.D.1    Kowalski, M.2    Fox, M.3    Aaronson, K.4
  • 6
    • 16344377117 scopus 로고    scopus 로고
    • Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure
    • Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005;111:1487-1491.
    • (2005) Circulation , vol.111 , pp. 1487-1491
    • Sackner-Bernstein, J.D.1    Skopicki, H.A.2    Aaronson, K.D.3
  • 7
    • 34748837363 scopus 로고    scopus 로고
    • Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: A double-blind placebo-controlled pilot study
    • Chen HH, Sundt TM, Cook DJ, Heublein DM, Burnett JC Jr. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study. Circulation. 2007;116:I134-I138.
    • (2007) Circulation , vol.116
    • Chen, H.H.1    Sundt, T.M.2    Cook, D.J.3    Heublein, D.M.4    Burnett Jr., J.C.5
  • 10
    • 0035045833 scopus 로고    scopus 로고
    • Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure
    • Lisy O, Lainchbury JG, Leskinen H, Burnett JC Jr. Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure. Hypertension. 2001;37:1089-1094.
    • (2001) Hypertension , vol.37 , pp. 1089-1094
    • Lisy, O.1    Lainchbury, J.G.2    Leskinen, H.3    Burnett Jr., J.C.4
  • 14
    • 0012140265 scopus 로고
    • Eine einfache colorimetrische Methode zur Inulinbestimmung fuer Nieren-Clearance-Untersuchungen bei Stoffwechselgesunden und Diabetikern
    • Fuhr J, Kaczmarczyk K, Kruttgen C. Eine einfache colorimetrische Methode zur Inulinbestimmung fuer Nieren-Clearance-Untersuchungen bei Stoffwechselgesunden und Diabetikern. Klin Wochenschr. 1955;33: 729-733.
    • (1955) Klin Wochenschr , vol.33 , pp. 729-733
    • Fuhr, J.1    Kaczmarczyk, K.2    Kruttgen, C.3
  • 15
    • 0022468421 scopus 로고
    • Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMPmediated process
    • Kurtz A, Della Bruna R, Pfeilschifter J, Taugner R, Bauer C. Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMPmediated process. Proc Natl Acad Sci U S A. 1986;83:4769-4773.
    • (1986) Proc Natl Acad Sci U S A , vol.83 , pp. 4769-4773
    • Kurtz, A.1    Della Bruna, R.2    Pfeilschifter, J.3    Taugner, R.4    Bauer, C.5
  • 16
    • 0030338446 scopus 로고    scopus 로고
    • Natriuretic peptides in the treatment of heart failure
    • Yasue H, Yoshimura M. Natriuretic peptides in the treatment of heart failure. J Card Fail. 1996;2:S277-S285.
    • (1996) J Card Fail , vol.2
    • Yasue, H.1    Yoshimura, M.2
  • 17
    • 0022634214 scopus 로고
    • Alpha-human atrial natriuretic polypeptide inhibits steroidogenesis in cultured human adrenal cells
    • Higuchi K, Nawata H, Kato K, Ibayashi H, Matsuo H. Alpha-human atrial natriuretic polypeptide inhibits steroidogenesis in cultured human adrenal cells. J Clin Endocrinol Metab. 1986;62:941-944.
    • (1986) J Clin Endocrinol Metab , vol.62 , pp. 941-944
    • Higuchi, K.1    Nawata, H.2    Kato, K.3    Ibayashi, H.4    Matsuo, H.5
  • 18
    • 0025611653 scopus 로고
    • Effects of atrial natriuretic peptide on renal arterioles: Morphometric analysis using microvascular casts
    • Kimura K, Hirata Y, Nanba S, Tojo A, Matsuoka H, Sugimoto T. Effects of atrial natriuretic peptide on renal arterioles: morphometric analysis using microvascular casts. Am J Physiol. 1990;259:F936-F944.
    • (1990) Am J Physiol , vol.259
    • Kimura, K.1    Hirata, Y.2    Nanba, S.3    Tojo, A.4    Matsuoka, H.5    Sugimoto, T.6
  • 20
    • 0023276509 scopus 로고
    • Untreated heart failure: Clinical and neuroendocrine effects of introducing diuretics
    • Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J. 1987;57:17-22.
    • (1987) Br Heart J , vol.57 , pp. 17-22
    • Bayliss, J.1    Norell, M.2    Canepa-Anson, R.3    Sutton, G.4    Poole-Wilson, P.5
  • 21
    • 0025153828 scopus 로고
    • Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)
    • Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724-1729.
    • (1990) Circulation , vol.82 , pp. 1724-1729
    • Francis, G.S.1    Benedict, C.2    Johnstone, D.E.3    Kirlin, P.C.4    Nicklas, J.5    Liang, C.S.6    Kubo, S.H.7    Rudin-Toretsky, E.8    Yusuf, S.9
  • 24
    • 34249036412 scopus 로고    scopus 로고
    • Impaired arginine-vasopressin-induced aldosterone release from adrenal gland cells in mice lacking the vasopressin V1A receptor
    • Birumachi J, Hiroyama M, Fujiwara Y, Aoyagi T, Sanbe A, Tanoue A. Impaired arginine-vasopressin-induced aldosterone release from adrenal gland cells in mice lacking the vasopressin V1A receptor. Eur J Pharmacol. 2007;566:226-230.
    • (2007) Eur J Pharmacol , vol.566 , pp. 226-230
    • Birumachi, J.1    Hiroyama, M.2    Fujiwara, Y.3    Aoyagi, T.4    Sanbe, A.5    Tanoue, A.6
  • 26
  • 28
    • 0034163914 scopus 로고    scopus 로고
    • The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction
    • Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000;35:681-689.
    • (2000) J Am Coll Cardiol , vol.35 , pp. 681-689
    • Dries, D.L.1    Exner, D.V.2    Domanski, M.J.3    Greenberg, B.4    Stevenson, L.W.5
  • 30
    • 18844423537 scopus 로고    scopus 로고
    • Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study
    • Klein L, O'Connor CM, Leimberger JD, Gattis-Stough W, Pina IL, Felker GM, Adams KF Jr, Califf RM, Gheorghiade M. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation. 2005;111:2454-2460.
    • (2005) Circulation , vol.111 , pp. 2454-2460
    • Klein, L.1    O'connor, C.M.2    Leimberger, J.D.3    Gattis-Stough, W.4    Pina, I.L.5    Felker, G.M.6    Adams Jr., K.F.7    Califf, R.M.8    Gheorghiade, M.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.